• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Revolutions Medical: Convicted libeler was informant behind SEC complaint

Revolutions Medical: Convicted libeler was informant behind SEC complaint

August 26, 2013 By Brad Perriello

Revoltions Medical: Convicted libeler was informant behind SEC complaint

Revolutions Medical (PINK:RMCP) said a civil complaint filed against it by the SEC last year relied on an informant who was later convicted in a $20 million libel suit.

Philip "Marty" Hicks was revealed as the informant in the SEC complaint accusing Revolutions Medical and CEO Ronald Wheet of issuing misleading press releases in 2010, according to a regulatory filing. The securities watchdog wants Revolutions to cough up $1.1 million and other civil penalties, and wants to bar Wheet from serving as an officer or director of SEC-regulated companies.

A South Carolina court awarded $20 million to Wheet and Revolutions Medical in July. Revolutions had accused Hicks of waging a "cyber smear campaign" against the company and its chief executive, and claimed that Hicks intentionally interfered with a DoD grant that Revolutions was slated to receive in September 2010.

" In April 2013, through discovery and answers to interrogatories, the SEC identified Phillip Maurice Hicks a/k/a Marty Hicks as its tipster and evoked client attorney privilege on all correspondence with Hicks," according to the filing. "Also in April 2013, the SEC identified that the testimony under oath of Richard Theriault was instrumental in bringing these allegations against the Company and its CEO."

Revolutions Medical sued Theriault, who according to the filing has declared bankruptcy, accusing him of fraud and RICO Act violations, among other claims.

According to company documents Hicks, under the user-name "Tazmanian353", had made libelous comments on Yahoo! Finance and Raging Bull online forums alleging that Revolutions was just a "shell company" without legitimate operations or real patents and that CEO Ron Wheet "lied in official documents" and made "fraudulent misleading statements."

Revolutions argued that Hicks’ comments were false and defamatory since the company owns patents, both granted and pending, for auto retractable safety syringe and certain medical imaging technology.

Filed Under: Legal News, News Well Tagged With: Revolutions Medical Corp., Securities & Exchange Commission (SEC)

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy